The HCPLive Allergy condition center page is a comprehensive resource for clinical news and insights on allergic and inflammatory diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for food and seasonal allergies, as well as allergic asthma and related conditions.
October 24th 2024
Aquestive Therapeutics plans to submit an NDA for Anaphylm in Q1 2025 based on topline results from the Oral Allergy Syndrome challenge study.
Caroline Nelson, MD: Biologics, JAK Inhibitors, Patch Testing for Allergic Reactions
In an interview segment with Nelson, she described elements from her AAAAI presentation, including when to use biologics or JAK inhibitors and what goes into patch testing for allergic skin reactions.
Largest Study on Food Allergies in Air Travel Uncovers Unmet Needs
February 26th 2023Dr. Christopher Warren discusses the study he presented at AAAAI 2023 Annual Meeting that found 98% of participants experienced added anxiety when traveling due to their food allergy, with a "lamentingly high number" of negative experiences.
Suboptimal Care Escalation for Severe Asthma in Black and Hispanic Patients
February 24th 2023A study from the AAAAI 2023 Annual Meeting reveals racial and ethnic disparities in the management of severe asthma and highlights the need for interventions to improve care escalation for Black and Hispanic/Latino patients.
Establishing Accurate Case Definitions for Childhood Respiratory and Skin Conditions
February 17th 2023A research letter addresses the challenges of accurately diagnosing asthma, atopic eczema, and allergic rhinitis in children under 5 years old and the use of Read codes and prescription data as diagnostic criteria.
Transplant-Acquired Atopy and Allergy Found to be More Common in Pediatric Liver Transplants
New research into risk factors for pediatric liver transplant patients indicated that atopy and allergy may follow a transplant and are more common among females and younger patients.
Frequent Allergies in Pediatric Atopic Dermatitis, Eosinophilic Esophagitis Patients in Puerto Rico
New data presented at ACAAI 2022 observed various trends in allergies associated with eczema and eosinophilic esophagitis, comparing observed data with that of patients in the United States.
Dupilumab Shows Significant Efficacy for EoE in Pooled Analysis
Weekly dupilumab 300 mg versus placebo demonstrated statistically significant, clinically meaningful improvements in histologic and endoscopic outcomes and symptoms in adults and adolescents with eosinophilic esophagitis.
Study Identifies Pathogenic Cell States, Transcriptional Programs Specific to Asthma
May 18th 2022In particular, airway epithelial cells (AEC) in allergic asthmatic (AA) were shown to upregulate mucus metaplasia, matrix-remodeling, and glycolytic programs while failing to upregulate antioxidant genes.